Neurology Symptom Articles & Analysis
9 news found
Krabbe disease initially manifests as irritability, developmental delay, and progressive muscle weakness; symptoms rapidly advance to difficulty swallowing, breathing, worsening developmental delay, and vision and hearing loss. ...
While this type of cancer is the most common form of a primary brain tumor, in most cases it does not spread to any other part of the body. Symptoms of Glioblastoma Symptoms of GBD may include headaches, weakness on one side of the body, double vision, speech difficulty or seizures. These general neurological symptoms can be ...
"We are very excited about the expansion of the range of neurological diseases that astrocyte cells (AstroRx®) could be used to treat. ...
Therefore, targeting these mechanisms could improve and even prevent neurological symptoms. Current approved treatments for GD do not cross the blood-brain barrier thus leaving a high unmet medical need for the development of novel advanced therapies that can target neuronopathic GD. ...
Counsel patients to seek immediate medical attention should signs or symptoms of CRS occur at any time. Neurologic Toxicities: Neurologic toxicities, which may be severe or life-threatening, occurred following treatment with ABECMA, including concurrently with CRS, after CRS resolution, or in the absence of CRS. ...
About Autism Spectrum Disorder (ASD) According to the Centers for Disease Control and Prevention (CDC), approximately 1 in 54 children has been identified with ASD. Core symptoms of ASD include impairments in social interaction, communication, and the presence of stereotyped repetitive behaviors. ...
Axial is advancing a pipeline of small molecule drugs with defined mechanisms of action that act on new targets to mitigate the impact of metabolites and bacteria in the gut linked to neurological disease pathology, progression, and symptoms. The company’s drug discovery approach is rooted in the groundbreaking research of its co-founder and chief ...
The authors predicted that the incidence rate of cSDH in United States in the aging VA and civilian populations will reach 121.4 and 17.4 cases per 100,000 persons, respectively, by 2030, at which time, approximately 60,000 cases of chronic SDH will occur each year in the United States.1 “We are excited to have the opportunity to investigate the Squid™ Liquid Embolic Device as a ...
Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicology and Applied Pharmacology 157(3):227-33. ...